500 related articles for article (PubMed ID: 11902986)
21. Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
Bräutigam M
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S53-6. PubMed ID: 9594938
[TBL] [Abstract][Full Text] [Related]
22. Terbinafine: a review of its use in onychomycosis in adults.
Darkes MJ; Scott LJ; Goa KL
Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
[TBL] [Abstract][Full Text] [Related]
23. German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
Bräutigam M; Nolting S; Schopf RE; Weidinger G
Br J Dermatol; 1996 Jun; 134 Suppl 46():18-21: discussion 38. PubMed ID: 8763463
[TBL] [Abstract][Full Text] [Related]
24. Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy.
Tosti A; Piraccini BM; Stinchi C; Venturo N; Bardazzi F; Colombo MD
J Am Acad Dermatol; 1996 Apr; 34(4):595-600. PubMed ID: 8601647
[TBL] [Abstract][Full Text] [Related]
25. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
[TBL] [Abstract][Full Text] [Related]
26. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
Ginter-Hanselmayer G; Weger W; Smolle J
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
[TBL] [Abstract][Full Text] [Related]
27. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
28. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial.
De Backer M; De Keyser P; De Vroey C; Lesaffre E
Br J Dermatol; 1996 Jun; 134 Suppl 46():16-7: discussion 38. PubMed ID: 8763462
[TBL] [Abstract][Full Text] [Related]
29. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.
Farkas B; Paul C; Dobozy A; Hunyadi J; Horváth A; Fekete G
Br J Dermatol; 2002 Feb; 146(2):254-60. PubMed ID: 11903236
[TBL] [Abstract][Full Text] [Related]
30. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
[TBL] [Abstract][Full Text] [Related]
31. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
Gupta AK; Lynch LE; Kogan N; Cooper EA
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
[TBL] [Abstract][Full Text] [Related]
32. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Gupta AK
Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
[TBL] [Abstract][Full Text] [Related]
33. An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis.
Mishra M; Panda P; Tripathy S; Sengupta S; Mishra K
Indian J Dermatol Venereol Leprol; 2005; 71(4):262-6. PubMed ID: 16394436
[TBL] [Abstract][Full Text] [Related]
34. Short term treatment of dermatophyte onychomycosis with terbinafine.
Goodfield MJ; Andrew L; Evans EG
BMJ; 1992 May; 304(6835):1151-4. PubMed ID: 1392793
[TBL] [Abstract][Full Text] [Related]
35. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials.
Krob AH; Fleischer AB; D'Agostino R; Feldman SR
J Cutan Med Surg; 2003; 7(4):306-11. PubMed ID: 14738099
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
[TBL] [Abstract][Full Text] [Related]
37. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
38. Study of oral itraconazole and terbinafine pulse therapy in onychomycosis.
Sikder AU; Mamun SA; Chowdhury AH; Khan RM; Hoque MM
Mymensingh Med J; 2006 Jan; 15(1):71-80. PubMed ID: 16467768
[TBL] [Abstract][Full Text] [Related]
39. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.
Salo H; Pekurinen M
Pharmacoeconomics; 2002; 20(5):319-24. PubMed ID: 11994041
[TBL] [Abstract][Full Text] [Related]
40. Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial.
Goodfield MJ
Br J Dermatol; 1992 Feb; 126 Suppl 39():33-5. PubMed ID: 1531926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
